Literature DB >> 31503369

Life-course trajectories of cannabis use: a latent class analysis of a New Zealand birth cohort.

Joseph M Boden1, Bhubaneswor Dhakal1, James A Foulds1, L John Horwood1.   

Abstract

BACKGROUND AND AIMS: Little is known about how cannabis use over the life-course relates to harms in adulthood. The present study aimed to identify trajectories of cannabis use from adolescence to adulthood and examine both the predictors of these trajectories and adverse adult outcomes associated with those trajectories.
DESIGN: A latent trajectory analysis of a longitudinal birth cohort (from birth to age 35 years). SETTING AND PARTICIPANTS: General community sample (n = 1065) from New Zealand. MEASUREMENT: Annual frequency of cannabis use (ages 15-35 years); childhood family and individual characteristics (birth to age 16 years); measures of adult outcomes (substance use disorders, ages 30-35 years; mental health disorders, ages 30-35 years; socio-economic outcomes at age 35 years; social/family outcomes at age 35 years).
FINDINGS: A six-class solution was the best fit to the data. Individuals assigned to trajectories with higher levels of cannabis use were more likely to have experienced adverse childhood family and individual circumstances. Membership of trajectories with higher levels of use was associated with increased risk of adverse outcomes at ages 30-35 years. Adjustment of these associations for the childhood family and individual predictors largely did not reduce the magnitude of the associations.
CONCLUSIONS: In New Zealand, long-term frequent cannabis use, or transition to such use, appears to be robustly associated with diverse harms in adulthood.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  Cannabis; birth cohort; latent trajectory analysis; longitudinal studies; mental health; psychosocial outcomes

Year:  2019        PMID: 31503369     DOI: 10.1111/add.14814

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

1.  Adult Psychiatric, Substance, and Functional Outcomes of Different Definitions of Early Cannabis Use.

Authors:  William E Copeland; Sherika N Hill; Lilly Shanahan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-08-17       Impact factor: 8.829

2.  Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis.

Authors:  Abigail C Wright; Julia Browne; Corinne Cather; Piper Meyer-Kalos; Kim T Mueser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-28       Impact factor: 5.760

3.  First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study.

Authors:  Jonathan Ross; Deepika E Slawek; Chenshu Zhang; Joanna L Starrels; Frances R Levin; Nancy L Sohler; Haruka Minami; Julia H Arnsten; Chinazo O Cunningham
Journal:  Pain Med       Date:  2021-12-11       Impact factor: 3.637

4.  The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review.

Authors:  Maryam Sorkhou; Rachel H Bedder; Tony P George
Journal:  Front Psychiatry       Date:  2021-02-16       Impact factor: 4.157

5.  Differences in child and adult biopsychosocial characteristics associated with regular cannabis use in individuals with and without cannabis use disorder.

Authors:  Katherine T Foster; Brooke J Arterberry; Robert A Zucker; Brian M Hicks
Journal:  Drug Alcohol Depend       Date:  2021-06-26       Impact factor: 4.852

Review 6.  Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.

Authors:  Benedikt Fischer; Dimitri Daldegan-Bueno; Joseph M Boden
Journal:  Drug Alcohol Rev       Date:  2020-05-20

7.  The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.

Authors:  Benedikt Fischer; Dimitri Daldegan-Bueno; Ross Bell; Joseph M Boden; Chris Bullen; Michael Farrell; Wayne Hall; David Newcombe
Journal:  Public Health Pract (Oxf)       Date:  2020-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.